Highlights from this issue

A universal artificial intelligence platform for collaborative management of cataracts (see page 1553) Universal AI-based multilevel platforms have the potential to make accurate cataract diagnoses and detect referral cases after evaluation of severity. The novel tertiary referral pattern achieved the

Highlights from this issue

Incidence of exudative age-related macular degeneration and treatment load under the Korean National health insurance system in 2010–15 (see page 1361) This population-based cohort study investigated the incidence of exudative age-related macular degeneration and associated use of ranibizumab and aflibercept

Effectiveness and safety of intravitreal aflibercept in patients with wet age-related macular degeneration treated in routine clinical practices across France: 12-month outcomes of the RAINBOW study

Background/aims To monitor treatment-naïve patients with wet age-related macular degeneration (wet AMD) receiving intravitreal aflibercept (IVT-AFL) in France. Methods RAINBOW (Real life use of intravitreal Aflibercept In FraNce – oBservatiOnal study in Wet age-related macular degeneration) is an ongoing, observational,

Highlights from this issue

Choriocapillaris and retinal vascular plexus density of diabetic eyes using Split-spectrum Amplitude-Decorrelation spectral domain optical coherence tomography angiography (see page 452) Capillary perfusion density in Choriocapillaris and retinal vascular plexuses in diabetic patients were observed in association with worsening retinopathy

Highlights from this issue

Micro-interventional endocapsular nucleus disassembly: novel technique and results of first-in-human randomized controlled study (see page 176) In a prospective, masked, multi-surgeon randomised clinical trail, the authors observed that microinterventional cataract fragmentation and endocapsular nucleus disassembly prior to conventional phacoemulsification safely

Efficacy of additional topical betamethasone in persistent cystoid macular oedema after carbonic anhydrase inhibitor treatments in retinitis pigmentosa

Objective We investigated the efficacy of additional topical betamethasone in persistent cystoid macular oedema (CMO) after carbonic anhydrase inhibitors (CAIs) therapy. Methods and analysis This retrospective cohort study included 16 eyes of 10 patients with retinitis pigmentosa (RP). All patients

WhatsApp WhatsApp'tan Bize Yazın